<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="308214">
  <stage>Registered</stage>
  <submitdate>13/07/2009</submitdate>
  <approvaldate>14/07/2009</approvaldate>
  <actrnumber>ACTRN12609000584235</actrnumber>
  <trial_identification>
    <studytitle>Impact of vitamin D status on risk of cardiovascular disease.</studytitle>
    <scientifictitle>Impact of vitamin D status on risk of cardiovascular disease in healthy adults.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil Known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>We are studying whether vitamin D deficiency increases cardiovascular risk</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Arterial stiffness and autonomic nervous system activity will be correlated with vitamin D status in a cross-sectional study. Subjects with vitamin D deficiency (25-hydroxy vitamin D &lt; 50 nmol/L) will be restudied 4-6 weeks after replenishment of vitamin D stores (100000 IU vitamin D orally in two doses two weeks apart).</interventions>
    <comparator>Uncontrolled</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: drugs</interventioncode>
    <interventioncode>Diagnosis / Prognosis</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Cross-sectional study: Simple linear regression relationship between serum 25-hydroxy vitamin D levels and pulse wave velocity (PWV) and baroreceptor sensitivity (BRS).
Interventional study: Change in PWV and BRS.</outcome>
      <timepoint>Cross-sectional study: One timepoint only.
Interventional study: 2-4 weeks after second (and final) dose of vitamin D.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Cross-sectional study: Simple linear regression relationship between serum 25-hydroxy vitamin D levels and augmentation index (AIx).
Interventional study: Change in AIx.</outcome>
      <timepoint>Cross-sectional study: One timepoint only.
Interventional study: 2-4 weeks after second (and final) dose of vitamin D.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy adults</inclusivecriteria>
    <inclusiveminage>30</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Treatment with 25-hydroxy vitamin D or 1,25-dihydroxy vitamin D
Beta-blocker medication
Diabetes mellitus
Atrial fibrillation</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>Cross-sectional study: Observational

Open interventional study: Subjects with 25 hydroxy vitamin D &lt; 50 nmol/L will be eligible to participate.</concealment>
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>10/07/2009</anticipatedstartdate>
    <actualstartdate>3/09/2009</actualstartdate>
    <anticipatedenddate />
    <actualenddate>24/10/2013</actualenddate>
    <samplesize>100</samplesize>
    <actualsamplesize>49</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Department of Health</primarysponsorname>
    <primarysponsoraddress>Citi Centre Building
11 Hindmarsh Square
Adelaide 
South Australia 5000</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Foundation Daw Park</fundingname>
      <fundingaddress>Repatriation General Hospital
Daw Rd
Daws Park
South Australia 5041</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The study aims to determine whether vitamin D deficiency is associated with increased cardiovascular risk and whether that risk is reversed by vitamin D replacement.</summary>
    <trialwebsite />
    <publication>Manuscript under preparation.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Repatriation General Hospital</ethicname>
      <ethicaddress>Daws Rd
Daw Park
South Australia 5041</ethicaddress>
      <ethicapprovaldate>20/04/2009</ethicapprovaldate>
      <hrec>42/07</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Dr Morton Burt</name>
      <address>Southern Adelaide Diabetes and Endocrine Services
Repatriation General Hospital
Daws Rd
Daw Park
South Australia 5041</address>
      <phone>+61 8 82751094</phone>
      <fax />
      <email>morton.burt@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Brenda Mangelsdorf</name>
      <address>Southern Adelaide Diabetes and Endocrine Services
Repatriation General Hospital
Daws Rd
Daw Park
South Australia 5041</address>
      <phone>+61 8 82751094</phone>
      <fax />
      <email>brenda.mangelsdorf@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Morton Burt</name>
      <address>Southern Adelaide Diabetes and Endocrine Services
Repatriation General Hospital
Daws Rd
Daw Park
South Australia 5041</address>
      <phone>+61 8 82751094</phone>
      <fax />
      <email>morton.burt@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Morton Burt</name>
      <address>Southern Adelaide Diabetes and Endocrine Services</address>
      <phone>61882751094</phone>
      <fax />
      <email>morton.burt@sa.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>